Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation
Parkinson Disease
About this trial
This is an interventional basic science trial for Parkinson Disease focused on measuring Deep Brain Stimulation, Parkinson Disease, Cognitive impairment, Movement Disorders, Brain Diseases
Eligibility Criteria
Inclusion Criteria: • Scheduled to undergo deep brain stimulation surgery under local anesthesia at Vanderbilt University Medical Center (Arm 1) Active deep brain stimulation system with implantable pulse generator capable of recording local field potentials (Arm 2) Diagnosis of Parkinson's disease as determined by a movement disorders specialist neurologist Age at least 18 Able to participate in intraoperative testing English speaking Exclusion Criteria: Age less than 18 Not able to participate in intraoperative testing (ex unable to comprehend instructions or follow directions)
Sites / Locations
- Vanderbilt University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Determination of DLPFC neurophysiology biomarkers of DBS associated cognitive impairment
Neurophysiology biomarkers of DBS mediated cognitive impairment following chronic stimulation
Neurophysiology recordings will be performed from dorsolateral prefrontal cortex (DLPFC) during deep brain stimulation surgery, with and without STN or GPI stimulation, at rest and during a working memory task.
Neurophysiology recordings will be performed from subthalamic nucleus (STN) or globus pallidus internus (GPI) with stimulation on and off, at rest and during a working memory task, in patients who have previously been implanted with DBS and have implantable pulse generators capable of recording local field potentials.